SCHEMBL7289886

SCHEMBL7289886

CCCCCCCOc1ccc2cc(C(=O)ON3C(=O)CCC3=O)ccc2c1

nearest known ligand 0.58

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
THRA P10827 2/20 0.54
TP53 P04637 1/20 0.48
TSHR P16473 1/20 0.48
PLA2G4B P0C869 1/20 0.47
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
THRB P10828 1/20 0.46
RARB P10826 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3683047 0.89 TP53 (0.57) THRATP53TSHRPLA2G4BTHRB
SCHEMBL3684567 0.87 SMPD1 (0.57) THRATSHRPLA2G4BTHRB
SCHEMBL3067042 0.86 RARB (0.60) THRATP53TSHRPLA2G4BTHRB
SCHEMBL7271786 0.86 TP53 (0.53) THRATP53TSHRPLA2G4BTHRB
SCHEMBL7280580 0.86 RARB (0.60) THRATP53TSHRPLA2G4BTHRB
SCHEMBL878923 0.85 HPGD (0.52) THRATP53TSHRPLA2G4BTHRB
SCHEMBL19750764 0.83 PLA2G2A (0.51) THRATP53TSHRPLA2G4BTHRB
SCHEMBL7273154 0.81 THRA (0.55) THRATSHRPLA2G4BTHRB
SCHEMBL3683009 0.80 SMN1; SMN2 (0.55) TSHRTHRB
SCHEMBL7272065 0.80 RARB (0.55) TP53TSHRPLA2G4BRARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0644199-B1 Cyclic antimicrobial peptides and preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 2000-07-19 EP disclosed
US-5693750-A MICROBIOCIDAL ACTION AGAINST PNEUMOCYSTIS INFECTIONS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-12-02 US disclosed
US-5569646-A TREATMENT OF PNEUMONIA; MICROBIOCIDES, FUNGICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-29 US disclosed
EP-0644199-A1 Cyclic antimicrobial peptides and preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-03-22 EP disclosed